Skip to main content

Mitral, Tricuspid, and Pulmonic Valve Disease

  • Chapter
  • First Online:
Handbook of Outpatient Cardiology

Abstract

Valvular heart disease is commonly identified during in the outpatient setting. These conditions require careful interdisciplinary care that is often best coordinated by a skilled Internist. This chapter will discuss the anatomy, pathology, role of multimodality imaging, and guideline based treatment options for patients with native mitral, tricuspid, and pulmonic valve disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

MR:

Mitral regurgitation

MS:

Mitral stenosis

PBMC:

Percutaneous balloon mitral commissurotomy

RF:

Regurgitant fraction

RHF:

Rheumatic fever

TEE:

Transesophageal echocardiography

References

  1. Baumgartner H, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23; quiz 101–2

    Article  Google Scholar 

  2. Munoz S, et al. Influence of surgery on the natural history of rheumatic mitral and aortic valve disease. Am J Cardiol. 1975;35:234–42.

    Article  CAS  Google Scholar 

  3. Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72–e227.

    PubMed  Google Scholar 

  4. Wilkins GT, et al. Percutaneous balloon dilation of the mitral valve: an analysis of echocardiographic variables related to outcome and mechanism of dilatation. British Heart Journal. 1988;60:299–308.

    Article  CAS  Google Scholar 

  5. Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019;12(2):353–62.

    Article  Google Scholar 

  6. Zoghbi WA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71.

    Article  Google Scholar 

  7. David TE, et al. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127(14):1485–92.

    Article  Google Scholar 

  8. Stone GW, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307–18.

    Article  Google Scholar 

  9. Obadia JF, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297–306.

    Article  Google Scholar 

  10. Nishimura RA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159–95.

    Article  Google Scholar 

  11. Nishimura RA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440–92.

    Article  Google Scholar 

  12. Feldman T, et al. Randomized comparison of prcutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844–54.

    Article  Google Scholar 

  13. Mauricio R, Kumbhani DJ. MitraClip: how do we reconcile the inconsistent findings of MITRA-FR and COAPT? Curr Cardiol Rep. 2019;21(12):150.

    Article  Google Scholar 

  14. Stout KK, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e698–800.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John C. Lisko .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lisko, J.C., Babaliaros, V.C. (2022). Mitral, Tricuspid, and Pulmonic Valve Disease. In: Bhargava, A.A., Wells, B.J., Quintero, P.A. (eds) Handbook of Outpatient Cardiology . Springer, Cham. https://doi.org/10.1007/978-3-030-88953-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-88953-1_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-88952-4

  • Online ISBN: 978-3-030-88953-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics